We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Differences Between Two Cancer-promoting Enzymes Discovered

News   Mar 28, 2019 | Original story from the University of Würzburg

 
Differences Between Two Cancer-promoting Enzymes Discovered

Structures of the catalytic domains of USP28 and USP25: USP28 is a constitutively active dimer and can bind and process ubiquitin (orange) at any time. In contrast, USP25 is a tetramer composed of two inter-linked USP28-like dimers (blue / gray and yellow / green) and this arrangement prevents binding of the substrate rendering the enzyme inactive. Credit: Rudolf Virchow Center of experimental biomedicine / University of Wuerzburg

 
 
Advertisement
 

RELATED ARTICLES

Common Diabetes Drugs May Help Prevent Parkinson’s Disease, Large Study Finds

News

Elevated risk of Parkinson’s disease among people with type 2 diabetes appears to be reduced by some medications used to treat their diabetes, finds a new study led by UCL researchers.

READ MORE

Alterations in Subcellular Traffic Increases Invasiveness of Radioresistant Cancer Cells

News

Scientists have revealed the molecular mechanism regulating the trafficking of lysosomes that increases the invasiveness of radioresistant cancer cells following radiotherapy.

READ MORE

Nanobiologic Approach Trains the Innate Immune System To Eliminate Tumor Cells

News

A novel type of cancer immunotherapy trains the innate immune system to help it eliminate cancer cells through the use of nanobiologics, tiny materials bioengineered from natural molecules that are partnered with a therapeutic component.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE